Press Releases
PANTHERx® Rare Selected by Chiesi Global Rare Diseases for the Distribution of Filsuvez® (birch triterpenes) topical gel
February 7, 2024
February 7, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it was selected by Chiesi Global Rare Diseases, a business unit of the Chiesi Group, for the...
Read MorePANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 7, 2023
December 7, 2023 PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual MMIT Patient Choice Award, once again, has the TOP Net Promoter Score for all independent specialty pharmacies in America for the Third Quarter of 2023 – the third top score...
Read MorePANTHERx® Rare Announces Partnership with Biocodex for the Distribution of DIACOMIT® (stiripentol) for the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam
June 27, 2022
June 27, 2022 PITTSBURGH – PANTHERx® Rare announces that it has been selected by Biocodex as their new exclusive U.S. pharmacy distribution partner for DIACOMIT® (stiripentol). DIACOMIT is a new molecular entity approved by the FDA in 2018 for the adjunctive...
Read MorePANTHERx Rare Celebrates Fifth Patient Choice Award Win
May 4, 2022
May 4, 2022 PITTSBURGH – For a fifth time, PANTHERx® Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award™. Since 2016, the Managed Markets Insights & Technology Zitter Health Insight’s (MMIT ZHI) Patient Choice...
Read MorePANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome
January 13, 2022
January 13, 2022 PANTHERx® Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distribution partner for a new FDA-approved medication, Recorlev®...
Read More2021 Marks Milestone Fourth Patient Choice Award for PANTHERx Rare
November 2, 2021
Read the Official PANTHERx Press Release. PANTHERx Rare has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™. “The results of the Managed Markets Insights & Technology Zitter Health Insights (MMIT...
Read MoreNo posts found